127 related articles for article (PubMed ID: 38084802)
21. SARS-CoV-2 Breakthrough Infections after introduction of 4 COVID-19 Vaccines, South Korea, 2021.
Yi S; Choe YJ; Kim J; Kim YY; Kim RK; Jang EJ; Lim DS; Byeon HR; Lee S; Park E; Kim SJ; Park YJ
Emerg Infect Dis; 2022 Mar; 28(3):753-756. PubMed ID: 35202529
[TBL] [Abstract][Full Text] [Related]
22. COVID-19 Vaccination in Patients With Inflammatory Bowel Disease and History of Reaction to Injectable Therapies.
Squire JD; Gonzalez-Estrada A; Caldera F; Farraye FA
Inflamm Bowel Dis; 2021 Jul; 27(8):1358-1360. PubMed ID: 33999204
[No Abstract] [Full Text] [Related]
23. Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis.
Washrawirul C; Triwatcharikorn J; Phannajit J; Ullman M; Susantitaphong P; Rerknimitr P
J Eur Acad Dermatol Venereol; 2022 Nov; 36(11):1947-1968. PubMed ID: 35666609
[TBL] [Abstract][Full Text] [Related]
24. Allergic Reactions After the Administration of COVID-19 Vaccines.
Bian S; Li L; Wang Z; Cui L; Xu Y; Guan K; Zhao B
Front Public Health; 2022; 10():878081. PubMed ID: 35655467
[TBL] [Abstract][Full Text] [Related]
25. Risk of lymphadenopathy from SARS-CoV-2 vaccination in Korea: a self-controlled case series analysis.
Kim MS; Kim B; Choi JP; Choi NK; Heo JY; Choi JY; Lee J; Kim SI
Epidemiol Health; 2023; 45():e2023090. PubMed ID: 37857339
[TBL] [Abstract][Full Text] [Related]
26. Interpersonal Trust Matters: Factors Associated With COVID-19 Vaccine Hesitancy in South Korea.
Jang SH
Asia Pac J Public Health; 2022 Jul; 34(5):600-602. PubMed ID: 35596572
[No Abstract] [Full Text] [Related]
27. Anaphylaxis and Related Events Following COVID-19 Vaccination: A Systematic Review.
Paul P; Janjua E; AlSubaie M; Ramadorai V; Mushannen B; Vattoth AL; Khan W; Bshesh K; Nauman A; Mohammed I; Bouhali I; Khalid M; Zakaria D
J Clin Pharmacol; 2022 Nov; 62(11):1335-1349. PubMed ID: 35794852
[TBL] [Abstract][Full Text] [Related]
28. Public Awareness and Sentiment toward COVID-19 Vaccination in South Korea: Findings from Big Data Analytics.
Choi YJ; Lee J; Paek SY
Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011550
[TBL] [Abstract][Full Text] [Related]
29. National prevalence and socioeconomic factors associated with the acceptance of COVID-19 vaccines in South Korea: a large-scale representative study in 2021.
Yang H; Kim MS; Rhee SY; Lee J; Cho W; Min C; Lee SW; Shin JI; Oh J; Choi Y; Lee JH; Kim H; Rahmati M; Yeo SG; Yon DK
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8943-8951. PubMed ID: 37782203
[TBL] [Abstract][Full Text] [Related]
30. COVID-19 Vaccination in Korea: Past, Present, and the Way Forward.
Nham E; Song JY; Noh JY; Cheong HJ; Kim WJ
J Korean Med Sci; 2022 Dec; 37(47):e351. PubMed ID: 36472087
[TBL] [Abstract][Full Text] [Related]
31. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK
PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759
[TBL] [Abstract][Full Text] [Related]
32. Accelerated national lot release on COVID-19 vaccines in Republic of Korea.
Yang M; Lee N; Ju JH; Park IS; Hong JT; Oh HJ
Biologicals; 2022 Jun; 77():24-27. PubMed ID: 35680495
[TBL] [Abstract][Full Text] [Related]
33. Imprecision in adverse event reports following immunization against HPV in Japan and COVID-19 in the USA, UK, and Japan-and the effects of vaccine hesitancy and government policy.
Inokuma Y; Kneller R
Eur J Clin Pharmacol; 2023 Feb; 79(2):269-278. PubMed ID: 36527455
[TBL] [Abstract][Full Text] [Related]
34. Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up using ultrasonography.
Kim B; Park Y; Kim EK; Lee SH
Clin Imaging; 2021 Nov; 79():201-203. PubMed ID: 34116295
[TBL] [Abstract][Full Text] [Related]
35. Vertigo and Dizziness After Coronavirus Disease-2019 Vaccination: A Nationwide Analysis.
Kim SH; Yon DK; Choi YS; Lee J; Park KH; Lee YJ; Park DC; Kim SS; Rim HS; Yeo SG
J Int Adv Otol; 2023 Jun; 19(3):228-233. PubMed ID: 37272641
[TBL] [Abstract][Full Text] [Related]
36. Trust Associated with South Korean Sojourners' Chinese COVID-19 Vaccination Intent and Concerns: A Qualitative Study.
Lin Y; Liu X
J Epidemiol Glob Health; 2023 Sep; 13(3):435-443. PubMed ID: 37261712
[TBL] [Abstract][Full Text] [Related]
37. Household Secondary Attack Rates of SARS-CoV-2 Omicron Variant, South Korea, February 2022.
Lim DS; Choe YJ; Man Kim Y; Lee SE; Jang EJ; Kim J; Park YJ
Emerg Infect Dis; 2022 Aug; 28(8):1731-1734. PubMed ID: 35798007
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination.
Zhou ZH; Cortese MM; Fang JL; Wood R; Hummell DS; Risma KA; Norton AE; KuKuruga M; Kirshner S; Rabin RL; Agarabi C; Staat MA; Halasa N; Ware RE; Stahl A; McMahon M; Browning P; Maniatis P; Bolcen S; Edwards KM; Su JR; Dharmarajan S; Forshee R; Broder KR; Anderson S; Kozlowski S
Vaccine; 2023 Jun; 41(28):4183-4189. PubMed ID: 37244808
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of anaphylaxis risk by skin testing with coronavirus disease 2019 messenger RNA vaccines on patients with anaphylaxis.
Pienkowski MM; Pienkowski SM
Ann Allergy Asthma Immunol; 2022 Jan; 128(1):101-103. PubMed ID: 34601091
[No Abstract] [Full Text] [Related]
40. Anaphylactic reactions to polyethylene glycol-containing bowel cleansing preparations after Moderna COVID-19 vaccination.
Schreiner M; Zobel C; Baumgarten U; Uhlmann T; Vandersee S
Endoscopy; 2022 May; 54(5):517-518. PubMed ID: 34710908
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
